Aratana’s stock falls after newest pet drug treatment fails study
December 18, 2017 at 14:00 PM EST
Aratana Therapeutics Inc.'s latest drug candidate did not pass an effectiveness study in dogs.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.